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CD38 genetic variation has been associated with autism spectrum disorders and
social anxiety disorder, which may result from CD38’s regulation of oxytocin secretion.
Converging evidence has found that the rs3796863 A-allele contributes to increased
social sensitivity compared to the CC genotype. The current study examined the
moderating role of CD38 genetic variants (rs3796863 and rs6449182) that have
been associated with enhanced (or reduced) social sensitivity on neural activation
related to neuroticism, which is commonly elevated in individuals with social anxiety
and depression. Adults (n = 72) with varying levels of social anxiety and depression
provided biological samples for DNA extraction, completed a measure of neuroticism,
and participated in a standardized emotion processing task (affect matching) while
undergoing fMRI. A significant interaction effect was found for rs3796863 x neuroticism
that predicted right amygdala-subgenual anterior cingulate cortex (sgACC) functional
connectivity. Simple slopes analyses showed a positive association between neuroticism
and right amygdala-sgACC connectivity among rs3796863 A-allele carriers. Findings
suggest that the more socially sensitive rs3796863 A-allele may partially explain the
relationship between a known risk factor (i.e., neuroticism) and promising biomarker (i.e.,
amygdala-sgACC connectivity) in the development and maintenance of social anxiety
and depression.
Keywords: CD38, fMRI, functional connectivity, neuroticism, psychopathology, oxytocin
INTRODUCTION
The multifunctional protein CD38 (Cluster of Differentiation 38) contributes to individual
differences in social cognition and behavior, which may result from CD38’s regulation of oxytocin
secretion (Jin et al., 2007). The majority of human research associating CD38 genetic variation
and social phenotypes has focused on two genetic variants of interest, rs3796863 (located in intron
7 on chromosome 4p15; Malavasi et al., 2008), and rs6449182 (located in a regulatory region in
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intron 1; Ferrero et al., 1999). Compared to individuals with the
rs3796863 CC genotype, A-allele carriers have been associated
with enhanced social sensitivity in the form of increased
parental sensitivity (Feldman et al., 2012), higher levels of
empathy and altruism (Liu et al., 2017), and decreased risk
of social impairments and autism spectrum disorders (Lerer
et al., 2010; Munesue et al., 2010). Individuals carrying the
A-allele have shown greater CD38 gene expression (Lerer
et al., 2010) and higher levels of unextracted plasma oxytocin
(Feldman et al., 2012) in comparison to individuals with
the CC genotype. However, contrary to previous results
demonstrating beneficial socioemotional outcomes associated
with the rs3796863 A-allele, our research group found that among
individuals who experienced higher levels of interpersonal stress,
A-allele carriers had higher levels of social anxiety and depression
over a 6-year period compared to those with the CC genotype
(Tabak et al., 2016).
As research on oxytocin (and related genes such as CD38),
has progressed, paradoxical results such as these have led to
the hypothesis that oxytocin enhances sensitivity to positive or
negative social stimuli (Olff et al., 2013; Shamay-Tsoory and
Abu-Akel, 2015). Work focusing on oxytocin system genes has
shown that variants associated with enhanced social sensitivity
may contribute to positive or negative outcomes depending on
relevant environmental factors and individual differences (Tabak,
2013). For example, several studies focused on variation in
the oxytocin receptor gene polymorphism rs53576 have found
that G-allele carriers who experienced childhood maltreatment
were at greater risk for mental health concerns (Bradley et al.,
2011; McQuaid et al., 2013; Andreou et al., 2018), even though
the majority of research examining this SNP has found the
G-allele to be beneficial or protective. Further research focusing
on variations in oxytocin system genes has shown that alleles
previously associated with beneficial social outcomes may also
be related to psychopathology when accounting for relevant
moderators (Kushner et al., 2018). Together, studies such as
these demonstrate that variation in oxytocin system genes,
including CD38, may contribute to enhanced levels of social
sensitivity, which can exacerbate the effects of environmental
stressors that contribute to the development and maintenance
of psychopathology (Tabak, 2013). This is particularly relevant
because positive associations between oxytocin and human
social processes have often overshadowed evidence of the
potential role of oxytocin in the development of psychopathology
(McQuaid et al., 2014).
In the present study, we sought to build on our previous
findings (Tabak et al., 2016) by investigating the underlying
mechanisms that connect CD38, social sensitivity, and
psychopathology. To examine this question, we focused on
how CD38 genetic variation moderated a neural circuit that
includes regions that have been associated with hyperactivation
in both depression and social anxiety; specifically, we examined
connectivity between the subgenual anterior cingulate cortex
(sgACC) and the amygdala.
A host of neuroimaging research has focused on the
sgACC and amygdala in depressed individuals (for review see
Ressler and Mayberg, 2007). There is evidence of heightened
activation in the amygdala and sgACC in individuals with
depression when viewing negative stimuli, and post-treatment
decreases in depression symptoms have been associated with
decreased activation in these regions (Ressler and Mayberg,
2007). Studies have also confirmed connectivity between the
amygdala and sgACC (Stein et al., 2007) and this neural circuit
has important relevance for emotion dysregulation, a prominent
characteristic of mood disorders (Joormann and Vanderlind,
2014). Findings have shown greater positive amygdala-sgACC
functional connectivity in depressed adolescents during resting-
state (Connolly et al., 2013) and while processing fearful facial
stimuli (Ho et al., 2014) compared to healthy controls. Similar
results have emerged in relatives of individuals diagnosed with
major depressive disorder (Wackerhagen et al., 2017). Studies of
individuals with social anxiety disorder have also found increased
amygdala activation during emotional face processing (Ball et al.,
2012) and when viewing negative (e.g., fearful or threatening)
stimuli compared to healthy controls (Freitas-Ferrari et al.,
2010; Gentili et al., 2016). In addition, meta-analytic effects for
increased activation in the sgACC have been found in individuals
with social anxiety disorder (Gentili et al., 2016). Thus, there
is evidence for amygdala and sgACC hyperactivation in both
depression and social anxiety disorder, and evidence for altered
functional connectivity between these regions in depression.
Elevated levels of neuroticism are a risk factor for depression
and anxiety, including social anxiety (Kotov et al., 2010).
Therefore, neuroticism is often examined as a trait level
individual difference that is positively associated with current
levels of anxiety and depression, as well as potentially higher
future levels of psychopathology. Neuroticism is also associated
with more negative responses to stress, increased reactivity
to threatening stimuli (Barlow et al., 2014), and heightened
activation in the amygdala and sgACC (Haas et al., 2007).
Given the relationship between neuroticism, psychopathology,
and threat reactivity, it is important to note that a meta-analysis
of neuroimaging studies examining neuroticism and emotion
processing did not find an association between neuroticism and
amygdala activation (Servaas et al., 2013). Rather, findings from
Servaas et al. (2013) suggest that the role of neuroticism in
amygdala activation appears to be related to altered connectivity
between the amygdala and frontal regions that result in emotion
dysregulation (Servaas et al., 2013). Indeed, Cremers et al.
(2010) found more inverse functional connectivity in the left
amygdala and anterior cingulate cortex among individuals with
higher levels of neuroticism when viewing negative stimuli.
Previous work by Pezawas et al. (2005) also found that inverse
connectivity between the amygdala and sgACC was associated
with increased harm avoidance (a construct highly correlated
with neuroticism that has been associated with affective disorder
symptomology; Jylhä and Isometsä, 2006) in short allele carriers
in the 5-HTTLPR polymorphism. In sum, previous findings
suggest that higher levels of neuroticism and altered connectivity
between the amygdala and sgACC may represent a common
neurobiological mechanism underlying the development of social
anxiety disorder and major depression.
In the present study, based on the associations between CD38
genetic variation and affective reactivity (Sauer et al., 2012),
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social anxiety, and depression (Tabak et al., 2016), we examined
the relationship between amygdala-sgACC connectivity and
neuroticism in individuals with varying levels of social anxiety
and depression. Using an a priori seed-based approach, we
used psychophysiological interaction (PPI) analysis to investigate
whether CD38 moderates the relationship between neuroticism
and amygdala-sgACC connectivity. We hypothesized that higher
levels of neuroticism would be related to positive connectivity
in this neural circuit in individuals with genotypes (i.e., the
rs3796863 A-allele) that have been associated previously with
enhanced social sensitivity. We also examined variation in a
second CD38 SNP, rs6449182, since there is evidence that this
polymorphism is functional and the G allele is associated with
increased CD38 expression (Jamroziak et al., 2009; Polzonetti
et al., 2012; but see Riebold et al., 2011).
METHODS
Participants
The present study includes a subsample from a randomized
controlled trial examining the effectiveness of two types of
psychotherapy for social anxiety disorder plus a healthy control
comparison group (see Craske et al., 2014 for full methods).
The current study focused on measurements obtained at
baseline before any intervention began and included participants
who provided a saliva sample for genotyping and fMRI data
(n = 81). Therefore, methods refer to only this aspect of the
study for these participants. Participants were 18–45 years old,
right-handed, and English speaking. They were either free of
medications, or stabilized on medication, and were not currently
involved in behavioral therapy (see Craske et al., 2014 for full
exclusion criteria).
No genotype could be determined for three participants and
six participants’ fMRI data were removed due to high levels
of motion-induced noise (>10% of images had a global signal
intensity >2.5 SD of mean, or were affected by motion of
>2.5 mm in any direction; Young et al., 2017). This resulted
in 72 participants (39 male; 33 female; Mean age = 27.56;
Age range = 18–43). Participants self-identified as Caucasian
(45.8%), Asian American (25%), Hispanic (13.9%), and Other
(15.3%). This study was carried out in accordance with the
recommendations of the UCLA Office for the Protection
of Human Research Subjects and approved by the UCLA
Institutional Review Board. All participants provided written
informed consent in accordance with the Declaration of Helsinki.
Materials
Neuroticism
The 12-item neuroticism subscale of the Eysenck Personality
Questionnaire–Revised Short form (EPQR–S; Eysenck et al.,
1985) was used to measure neuroticism (α = 0.86).
Psychiatric Diagnosis
Even though we focused on trait levels of neuroticism, the
majority of participants (n = 57) met diagnostic criteria for
social anxiety disorder. Fifteen additional participants did not
meet criteria for any diagnosis (i.e., they were a healthy control
comparison group). Diagnoses were based on the Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition through the
use of the Anxiety Disorders Interview Schedule-IV (Brown et al.,
1994) that were conducted by trained interviewers. Individuals
who met criteria for a clinical disorder all had a current diagnosis
of social anxiety disorder that was either principal or co-principal,
with a clinical severity rating of four or higher (Craske et al.,
2014). Healthy controls did not have a current or previous
psychiatric diagnosis. Among participants who met criteria for
social anxiety disorder, 13.9% (rs3796863 CC n = 7, A carrier
n = 3; rs6449182 CC n = 8, G carrier n = 2) were currently
taking medication for anxiety, depression, or “another emotional
problem” (see Burklund et al., 2015 for additional details).
Genotyping
Participants provided saliva samples using Salivettes (Sarstedt,
Germany). DNA Extraction and genotyping was performed by
Genomeadvisors Inc., La Mirada, CA, United States. CD38
SNPs were genotyped using Taqman SNP Genotyping Assays
(rs6449182: C___1216863_10; rs3796863: C___1216944_10)
with the ABI 7900 Sequence Detection System.
Procedure
The EPQR-S was administered 1–2 weeks before participants
completed their fMRI session. Before beginning the fMRI
procedure, participants practiced the reactivity task that involved
viewing and matching images of emotional facial expressions
and geometric shapes (Hariri et al., 2002). In the present study,
our interest was in examining neural reactivity to negative
stimuli (angry, disgusted, or fearful emotional expressions)
obtained from the NimStim Face Stimulus set (Tottenham et al.,
2009). We collapsed across facial expressions in analyses to
examine responses to negative facial expressions in general
compared to shape matching. This resulted in two conditions:
affect match and shape match. Our focus of analysis was
on the contrast between matching affect vs. matching shapes,
which is a well-validated method of assessing neural activation
associated with viewing emotionally evocative human stimuli
while controlling for attention and motoric responses (as
described in Burklund et al., 2015). This task has been used
in previous research examining amygdala-sgACC functional
connectivity and depression (Pezawas et al., 2005). Participants
also completed two other conditions in which they were asked
to engage in affect labeling or gender labeling of the face stimuli
(see Burklund et al., 2015 for further details). Regressors for these
stimuli were included in first level models, but as they are not
the focus of the current investigation, they are not reported on
here. A previous study by our research group (Burklund et al.,
2015) also examined neural activation across different clinical
subgroups compared to healthy controls in the bilateral amygdala
as well as right ventral lateral prefrontal cortex during affect
match vs. shape match. In contrast, the current study examined
trait levels of neuroticism and focused on functional connectivity
between the amygdala and sgACC.
As described by Burklund et al. (2015) we used a block design
for stimuli presentation with four blocks per condition (affect
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match, shape match, affect label, gender label; all conditions
were counterbalanced) and six trials per block (trials lasted
5 s, resulting in 30 s blocks). Preceding the stimuli blocks
were 10 s fixation crosshairs and 3 s instruction cues. The
present analyses build on the prior work published in Burklund
et al. (2015) by examining genetic contributions to functional
connectivity between areas as a function of neuroticism rather
than focusing on group differences in neural activation as was
done in the prior work. A Macintosh MacBook Pro computer
with MacStim software (WhiteAnt Occasional Publishing)1 and
high-resolution goggles (Resonance Technology, Inc.) were used
to present stimuli. Responses were collected with an fMRI-
compatible button box through a custom USB interface.
fMRI Image Acquisition
Magnetic resonance images were acquired using a Trio 3.0
Tesla Siemens MRI scanner at the UCLA Ahmanson-Lovelace
Brain Mapping Center. For each participant, a high-resolution
structural T2-weighted echoplanar imaging volume (spin-echo,
TR = 5000 ms, TE = 34 ms, matrix size = 128 × 128,
resolution = 1.6 mm × 1.6 mm × 3 mm, FOV = 200 mm, 36
slices, 3 mm thick, flip angle = 90◦, bandwidth = 1302 Hz/Px)
was acquired coplanar with the functional scans. Four functional
runs were acquired, with a total of 344 volumes (gradient-echo,
TR = 3000 ms, TE = 25 ms, flip angle = 90◦, matrix size = 64× 64,
resolution = 3.1 mm x 3.1 mm x 3.0 mm, FOV = 200 mm, 36 axial
slices, 3 mm thick, bandwidth = 2604 Hz/Px).
fMRI Pre-processing and Analysis
Imaging data were analyzed using SPM8 (Wellcome Trust
Centre for Neuroimaging, University College London,
United Kingdom)2. Functional images for each participant
were realigned to correct for head motion, co-registered to the
high-resolution structural images, normalized into a standard
stereotactic space as defined by the Montreal Neurological
Institute and smoothed with an 8 mm Gaussian kernel FWHM.
Experimental blocks were modeled using a boxcar function
convolved with the canonical hemodynamic response. Motion
parameters were included in the model as regressors of no
interest. Linear contrasts for affect match vs. shape match
were computed at the first-level for each participant using a
fixed-effects model. PPI analyses (Friston et al., 1997) were
implemented using generalized PPI (gPPI) within SPM8
(McLaren et al., 2012). These analyses were used to examine
whether the interaction between neuroticism and CD38 variation
predicted functional connectivity between the amygdala and the
sgACC. The right and left amygdala were used as separate seed
regions for these analyses [anatomically defined ROI; Automated
Anatomical Labeling (AAL) library]. We conducted both an
ROI-based analysis and a whole-brain analysis to investigate
general alterations in right and left amygdala connectivity,
focusing on the sgACC. A spherical sgACC ROI (6 mm radius)
was created based on coordinates in a previous study examining
the moderating role of genetic variation on amygdala-sgACC
1www.Brainmapping.org/WhiteAnt
2http://www.fil.ion.ucl.ac.uk
connectivity during the same affect match task used in the
present study (Pezawas et al., 2005; MNI coordinates: x = 0,
y = 37, z = -2).
Statistical Analysis
ROI analyses: All continuous independent variables and
covariates were mean centered before analyses. Using hierarchical
multiple linear regression, separate analyses were conducted
for each CD38 SNP that included the following predictors
of right (or left) amygdala-sgACC connectivity: (a) the main
effect of genotype, (b) the main effect of neuroticism, and
(c) the interaction effect of genotype x neuroticism. Following
the recommendations of Keller (2014) we also ran analyses
with the inclusion of additional covariates to assess the
robustness of findings including: self-reported race/ethnicity
(Asian, Hispanic, Other; Caucasians were designated as the
comparison group), gender, age, medication status, group (i.e.,
clinical vs. healthy controls), and all genotype x covariate as
well as neuroticism x covariate interactions. The addition of all
robustness covariates and their interactions did not alter the
significance of any primary interaction effects.
Significant interactions were followed by simple slopes
analyses to examine the main effects of neuroticism for
each genotype group. Analyses were conducted using
SPSS 24 and the PROCESS macro (Hayes and Little,
2017). Figure 1 was created using Stata version 14.
Bonferroni correction was used to correct for multiple
testing for the four primary gene x neuroticism tests (i.e.,
rs3796863 x neuroticism for left and then right amygdala, and
the same two tests for rs6449182), resulting in a threshold
of p < 0.0125.
As in previous studies (Feldman et al., 2012; Sauer et al.,
2012; Tabak et al., 2016), we used dominant coding for rs3796863
(CC = 0; A-allele carriers [AC and AA] = 1). Based on previous
work (Jamroziak et al., 2009; Polzonetti et al., 2012), rs6449182
was also coded in a dominant manner (CC = 0; G-allele carriers
FIGURE 1 | Interaction of rs3796863 x right amygdala-sgACC functional
connectivity predicting neuroticism.
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[CG or GG] = 1). Genotype frequencies for the total sample of
participants who provided genetic and fMRI data were in Hardy–
Weinberg Equilibrium (rs3796863: χ2 = 2.6, p = 0.11, rs6449182:
χ2 = 2.4, p = 0.12).
Whole brain analyses: Group level whole brain multiple
regression analyses were conducted, entering connectivity SPM
images for the contrast “Affect Match – Shape Match.”
Regressors included in the model were the CD38 genotype,
neuroticism, and CD38 x neuroticism interaction effects.
Gender, age, race/ethnicity, medication status, group, and
all genotype x covariate as well as neuroticism x covariate
interactions were entered as covariates of no interest.
RESULTS
Table 1 displays sample demographics, means, standard
deviations, and genotype frequencies. No significant
differences in demographic variables were found between
dichotomized genotype groups. Our interest in focusing
on neuroticism as a trait level individual difference that
reflects anxiety and depression symptoms was confirmed
by high correlations (rs = 0.73) between neuroticism and
the General Distress Anxiety and Depression scales from
the Mood and Anxiety Symptoms Questionnaire (Watson
et al., 1995). We first examined the correlation between
CD38 genotype and neuroticism (including gender, age,
race/ethnicity, medication status, and group as covariates)
and found no associations between rs3796863 genotype (A/C
or A/A genotypes coded 1; C/C genotype coded 0) (r = 0.02,
p = 0.88) or rs6449182 genotype and neuroticism (G/G or
C/G genotypes coded 1; C/C genotype coded 0) (r = 0.05,
p = 0.71).
CD38 Variant rs3796863
We used hierarchical multiple linear regression analysis and
found a main effect of CD38 rs3796863 genotype on right
amygdala-sgACC functional connectivity (p = 0.017), but no
main effect of neuroticism (see Table 2). However, there was
also a significant rs3796863 x neuroticism effect (p = 0.002) that
maintained significance following multiple test correction. As
shown in Table 2 and Figure 1, simple slopes analysis showed
a positive association between neuroticism and right amygdala-
sgACC connectivity for A-allele carriers, but the simple slope for
individuals with the CC genotype was not significant. There were
also no main or interaction effects of genotype or neuroticism
when examining left amygdala-sgACC connectivity (See Table 2).
CD38 Variant rs6449182
We followed the same steps and conducted hierarchical multiple
linear regression analysis and found no main or interaction effects
involving CD38 rs6449182 genotype (see Table 3).
Whole Brain Analyses
Full results of whole brain analyses are presented in
Supplementary Tables S1, S2).
DISCUSSION
The present findings are the first showing evidence of a
moderating role for CD38 genetic variation on the association
between neuroticism and amygdala-sgACC connectivity.
Specifically, there was a positive association between neuroticism
and right amygdala-sgACC functional connectivity among
rs3796863 A-allele carriers. Thus, A-allele carriers with
lower levels of neuroticism showed more inverse functional
connectivity between right amygdala and sgACC whereas
A-allele carriers with higher levels of neuroticism showed more
positive connectivity. For illustrative purposes, we created
Supplementary Figure S1 to decompose patterns of functional
connectivity. Results suggested that the present findings may
be driven by A-allele carriers with lower levels of neuroticism,
potentially due to better regulation of the amygdala. This finding
suggests that results from our previous work, in which we
found increased risk for social anxiety and depression over time
among rs3796863 A-allele carriers who experienced greater
interpersonal stress, may have been specific to individuals with
higher levels of neuroticism, who were oversampled (Tabak et al.,
2016). These results also follow the pattern shown by McQuaid
et al. (2016) who found higher levels of depression and suicidal
ideation among individuals with the rs3796863 AA genotype
compared to C-allele carriers (but see Parris et al., 2018; Handley
et al., 2019). Results also suggest that accounting for neuroticism
in future studies of CD38 genetic variation may help to explain
discrepant associations of the rs3796863 A-allele with outcomes
such as greater empathy and altruism (Liu et al., 2017), reduced
risk of autism spectrum disorders (Munesue et al., 2010), but also
higher levels of depression and suicidal ideation (McQuaid et al.,
2016). Since the directionality of associations among A-allele
carriers has differed across studies, further research that accounts
for levels of neuroticism is needed. More broadly, the present
finding adds to results from previous studies suggesting a role for
oxytocin system genetic variants in enhanced social sensitivity
(Tabak, 2013).
The present results are also in agreement with studies showing
increased connectivity between the amygdala and sgACC in
individuals with depression during a facial affect recognition
task for fearful stimuli (Ho et al., 2014) and among adult first-
degree relatives of individuals with major depressive disorder
when performing a negative affect matching task (Wackerhagen
et al., 2017). In addition, a previous report found that the same
neural circuit examined in the present study was moderated
by genetic variation in the serotonin system (i.e., more inverse
amygdala-sgACC connectivity was related to higher levels of
harm avoidance among 5-HTTLPR short allele carriers; Pezawas
et al., 2005). In a previous study examining the relationship
between neuroticism and amygdala-anterior cingulate cortex
(ACC) connectivity, Cremers et al. (2010) found that neuroticism
was related to more inverse functional connectivity between the
left amygdala and ACC. In the present study, our analyses did
not identify a significant relationship between the left amygdala
and the ACC; however, whole brain analyses showed a significant
interaction effect of rs3796863 x neuroticism predicting positive
functional connectivity between the right amygdala and the
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TABLE 1 | Descriptive statistics for rs3796863, rs6449182, and major study variables.
Variable All participants rs3796863
A-Allele Carriers
rs3796863 CC
Homozygotes
rs6449182
G-Allele Carriers
rs6449182 CC
Homozygotes
Gender t = −1.34 (70) t = −0.478 (69)
Female 34 (47.2%) 16 (57.1%) 18 (40.9%) 10 (52.6%) 24 (46.2%)
Male 38 (52.8%) 12 (42.9%) 26 (59.1%) 9 (47.4%) 28 (53.8%)
t = 1.44 (58.5) t = −1.22 (69)
Age 27.56 (6.51) 26.21 (6.33) 28.44 (6.54) 29.14 (7.13) 26.94 (6.3)
t = 0.156 (70) t = −0.101 (69)
Neuroticism 6.83 (3.59) 6.75 (3.72) 6.89 (3.54) 7.00 (2.85) 6.90 (3.76)
Race/ethnicity χ2 = 2.53 (3, 72) χ2 = 2.02 (3, 71)
Caucasian 33 (45.8%) 15 (53.6%) 18 (40.9%) 10 (52.6%) 22 (42.3%)
Hispanic/Latino 10 (13.9%) 2 (7.1%) 8 (18.2%) 2 (10.5%) 8 (15.4%)
Asian American/Pacific Islander 18 (25%) 6 (21.4%) 12 (27.3%) 3 (15.8%) 15 (28.8%)
Other 11 (15.3%) 5 (17.9%) 6 (13.7%) 4 (21.1%) 7 (13.5%)
CD38 genotype
AA 8 (11.1%) – – – –
AC 20 (27.8%) – – – –
CC 44 (61.81%) – – –
TABLE 2 | (a) CD38 rs3796863 and neuroticism predicting right amygdala-sgACC functional connectivity. (b) CD38 rs3796863 and neuroticism predicting left
amygdala-sgACC functional connectivity.
Independent variable b β SE R2
(a)
CD38 genotype −0.312* −0.282 0.128 0.066
Neuroticism 0.020 0.132 0.018 0.097
Genotype x Neuroticism 0.107** 0.798 0.033 0.217
Simple Slope for A-allele carriers
Neuroticism 0.082** 0.608 0.021 0.370
Simple Slope for C/C genotype
Neuroticism −0.025 −0.162 0.024 0.026
(b)
CD38 genotype 0.005 0.005 0.125 0.000
Neuroticism −0.003 −0.020 0.017 0.000
Genotype x Neuroticism 0.052 0.409 0.035 0.032
Simple Slope for A-allele carriers
Neuroticism 0.028 0.244 0.022 0.060
Simple Slope for C/C genotype
Neuroticism −0.024 −0.151 0.024 0.023
The addition of robustness covariates or their interactions did not alter the significance of the primary interaction effects or the significance of simple slopes.
ACC. One potential explanation for the discrepancy between
the present results and those from Cremers et al. (2010)
is that the sample in the study by Cremers and colleagues
included all healthy individuals, whereas our sample included
healthy individuals as well as individuals with anxiety and
depressive disorders.
Although previous studies have examined the role of genetic
variation in 5-HTTLPR and neuroticism (Pluess et al., 2010;
Kuepper et al., 2012), to date, there is limited research examining
oxytocin related genetic variants and neuroticism. This seems
like an important oversight since, in addition to its role in
social processes, oxytocin is associated with stress responsivity
(Engert et al., 2016; Alley et al., 2019) and evidence suggests
that early life adversity can alter the oxytocin system (Bradley
et al., 2011; Grimm et al., 2014; Smearman et al., 2016). In
addition, neuroticism not only predicts psychopathology over
time (Kendall et al., 2015), but it’s also associated with negative
interpersonal outcomes such as increased reactivity to stressful
events following conflict (Suls et al., 1998), a tendency to use
negative forms of coping following interpersonal stress (Gunthert
et al., 1999), and negative marital outcomes including divorce
(Kelly and Conley, 1987). As studies continue to elucidate
potential relationships between oxytocin and psychopathology
(McQuaid et al., 2014; Gottschalk and Domschke, 2018), the
present results suggest that neuroticism should be a target of
future oxytocin research. This enhanced focus on neuroticism
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TABLE 3 | (a) CD38 rs6449182 and neuroticism predicting right amygdala-sgACC functional connectivity. (b) CD38 rs6449182 and neuroticism predicting left
amygdala-sgACC functional connectivity.
Independent variable b β SE R2
(a)
CD38 genotype −0.011 −0.009 0.149 0.000
Neuroticism 0.023 0.145 0.019 0.021
Genotype x Neuroticism −0.061 −0.382 0.050 0.042
Simple Slope for G-allele carriers
Neuroticism −0.027 −0.200 0.033 0.040
Simple Slope for C/C genotype
Neuroticism 0.033 0.207 0.023 0.043
(b)
CD38 genotype 0.095 0.083 0.138 0.007
Neuroticism −0.001 −0.005 0.018 0.007
Genotype x Neuroticism 0.016 0.107 0.048 0.009
Simple Slope for G-allele carriers
Neuroticism 0.013 0.060 0.051 0.004
Simple Slope for C/C genotype
Neuroticism −0.003 −0.026 0.018 0.001
The addition of robustness covariates or their interactions did not alter the significance of the primary interaction effects or the significance of simple slopes.
would be consistent with elevated levels of anxiety and emotional
reactivity to negative events that have been seen in mice with
deletion of the CD38 gene (Martucci et al., 2019).
Exploratory whole brain analyses showed main effects of
neuroticism on regions that are considered part of the default
mode network, such as the temporoparietal junction, precuneus,
and sgACC (Menon, 2011; Li et al., 2014). These findings are
consistent with prior work demonstrating altered connectivity of
functional brain networks, including the default mode network,
in anxiety disorders and depression (Sylvester et al., 2012; Zhu
et al., 2012). Future work exploring altered network connectivity
in the context of oxytocin would be of much interest in
this regard. Additional whole brain analyses suggested that
the interaction of genotype and neuroticism might impact
other neural networks, including the ACC, dorsal medial
prefrontal cortex, and inferior frontal gyrus regions. These
regions have been implicated in a variety of functions including
the explicit regulation of emotional reactivity in limbic brain
regions (Ochsner and Gross, 2008). The current study was not
designed to investigate emotion regulation, instead focusing
on emotional reactivity to negative stimuli, but investigation
of how neuroticism and CD38 variants interact to impact
regulation of emotional reactions would be of interest in
future research.
The present study has several strengths including
a sample of participants with a wide range of social
anxiety and depression levels, the focus on a continuous
measure of psychopathology risk (i.e., neuroticism), and
the examination of genetic variation of a neural circuit
through functional connectivity analysis. In addition, the
significant gene x neuroticism interaction effect found
in the present study withstood multiple test correction
and the addition of many robustness covariates and their
interaction effects. However, several limitations must also
be noted. Although the present sample is slightly larger
than other studies examining CD38 genetic moderation of
neural activation (Sauer et al., 2012, 2013), based on current
recommendations (Duncan and Keller, 2011), our sample is
small for a GxE interaction study. In addition, the size of
the interaction effect found in the present study (R2 = 0.11
with robustness covariates; R2 = 0.217 without robustness
covariates) is much larger than current estimates for typical
GxE effects (Duncan and Keller, 2011). Another limitation
is our racially/ethnically heterogeneous sample. To account
for this in our statistical analysis, we included race/ethnicity
and genotype x race/ethnicity interactions as covariates,
which is an established method to statistically reduce the
potential effects of population stratification (Keller, 2014).
However, the size of our sample prevented us from conducting
additional analyses to examine the generalizability of effects
within and across racial/ethnic subgroups. Based on these
limitations, replication studies with a larger sample size
are necessary, and the present results should be viewed as
preliminary in nature.
There is evidence that CD38 gene expression is positively
associated with levels of endogenous oxytocin (Kiss et al.,
2011), but the way in which CD38 SNP rs3796863 may
influence genetic expression is not yet known. Therefore, the
present findings suggest that rs3796863 may be tagging a
functional SNP that was not genotyped in our study (Lin
et al., 2007). In contrast, several studies have found evidence
for a functional role for rs6449182 (Jamroziak et al., 2009;
Polzonetti et al., 2012), but variation in this SNP was not
associated with our outcome. The present study also did not
include a direct measurement of endogenous oxytocin, which
precludes us from examining the relationship between CD38
genetic variation, circulating levels of oxytocin, and neuroticism.
However, previous work has found an association between CD38
genetic variation and differences in levels of unextracted oxytocin
(Feldman et al., 2012).
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Conclusion
In sum, we found a positive association between neuroticism
and right amygdala-sgACC functional connectivity in rs3796863
A-allele carriers. Given the correlational nature of functional
connectivity analysis, the extent to which the right amygdala
is affecting the sgACC or vice versa cannot be determined.
However, the present results suggest that the more socially
sensitive rs3796863 A-allele may partially explain the
relationship between a known risk factor (i.e., neuroticism) and
promising biomarker (i.e., amygdala-sgACC connectivity) in the
development and maintenance of social anxiety and depression.
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